Vermeyen Els Dr. SRL

Vermeyen Els Dr. reported total assets of 338,680 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).

Company number (CBE) 0731.564.892
3920 Lommel
active in Medical specialists activities (NACE 86220)
operating since 24 Jul 2019 (≈ 7 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Vermeyen Els Dr. shows with a free account.

See the score
Profile
SRL since 2019
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result151,466 €
Equity181,387 €
Cash126,122 €
EBITDA190,427 €
Total assets338,680 €
The line marks its sector median: 72.2% (8672 companies).

Change 2022 → 2025: Equity -40 % Total assets -28 %

Accounts of the company itself (not consolidated).

The full file covers 7 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Vermeyen Els Dr.'s annual accounts

20252024202320222021
Net result151,466 €
Equity181,387 €
Cash126,122 €
EBITDA190,427 €
Total assets338,680 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 29 Jun 2026
  • Year ended 31 Dec 2024filed on 15 Jul 2025
  • Year ended 31 Dec 2023filed on 30 Jul 2024
  • Year ended 31 Dec 2022filed on 11 Jul 2023
  • Year ended 31 Dec 2021filed on 31 Aug 2022

Vermeyen Els Dr.'s financial analysis

Management and control of Vermeyen Els Dr.

1 active director(s) in the register.

Vermeyen Els Dr.'s shareholders and holdings →

Vermeyen Els Dr.'s publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0731.564.892
VAT number
No VAT activity declared to the CBE
Peppol
Registered · 0208:0731564892 · as of 10 Nov 2026
Legal form
SRL
Incorporated
24 Jul 2019
Registered office
3920 Lommel
Latest accounts
2025 · filed on 29 Jun 2026
Activity
Medical specialists activities (NACE 86220)

Vermeyen Els Dr. (SRL) has been based in Lommel since 2019, active in: medical specialists activities. For 2025, it reports a net profit of 151,466 € and equity of 181,387 €; its revenue is not published.

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Vermeyen Els Dr.

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Vermeyen Els Dr.

What is the revenue of Vermeyen Els Dr.?

Vermeyen Els Dr. files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Vermeyen Els Dr.?

According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Vermeyen Els Dr.. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0731564892. Its company number (CBE) is 0731.564.892.

Where is the registered office of Vermeyen Els Dr.?

According to the CBE register, the registered office of Vermeyen Els Dr. is in 3920 Lommel.

What is the equity of Vermeyen Els Dr.?

At the close of the 2025 financial year, the equity of Vermeyen Els Dr. amounts to 181,387 €, a solvency of 53.6% of total assets.

Who manages Vermeyen Els Dr.?

The register lists 1 active mandates at Vermeyen Els Dr.. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Vermeyen Els Dr.

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 10 Aug 2026

No credit card, no commitment.

What each plan unlocks →